S1P-S1PR3-RAS promotes the progression of S1PR3hi TAL1+ T-cell acute lymphoblastic leukemia that can be effectively inhibited by an S1PR3 antagonist-Reference-Cited by-同舟云学术

S1P-S1PR3-RAS promotes the progression of S1PR3hi TAL1+ T-cell acute lymphoblastic leukemia that can be effectively inhibited by an S1PR3 antagonist

Published:2023-08-17 Issue:10 Volume:37 Page:1982-1993
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Zhu Dan^ORCID,Jiang Tingting^ORCID,Ma Deyu,Zhang Hongyang,Zhang Jia,Lv Wenqiong,Gong Maoyuan,Wang Haobiao,Liu Ziyang,Su Hongyu,Zeng Lamei,Liu Shan,Tang Shi,Yang Bijie,Tshavuka Filippus I.,Fu Guo,Liu Zidai,Peng Danyi,Liu Haiyan,Yan Zijun^ORCID,Cao Ziyang,Zhao Hui,He Tong-Chuan,Yu Jie,Shu Yi^ORCID,Zou Lin

Funder

National Natural Science Foundation of China

Chongqing Science and Technology Commission

The Chongqing Science and Technology Bureau Major Project

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-023-02000-0.pdf

Reference50 articles.

1. Belver L, Ferrando A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat Rev Cancer. 2016;16:494–507.

2. Homminga I, Pieters R, Langerak AW, de Rooi JJ, Stubbs A, Verstegen M, et al. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell. 2011;19:484–97.

3. Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017;49:1211–8.

4. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1:75–87.

5. Cordo V, van der Zwet JCG, Cante-Barrett K, Pieters R, Meijerink JPP. T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies. Blood Cancer Discov. 2021;2:19–31.